Serial 98396603
Live / Applied — Second extension granted (statement of use) (as of 13 Nov 2025)
What this means for you
Not registered yet, but its 07 Feb 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98396603
- Mark type
- Design / logo
- Filed
- 07 Feb 2024
- Published for opposition
- 08 Oct 2024
- Attorney of record
- Douglas A. Rettew
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of eye diseases, disorders, and conditions; ophthalmologic pharmaceutical preparations
Owner
- BIOGEN INTERNATIONAL GMBH, BAAR, CH
- Biogen MA Inc., Cambridge, MA, US
- Biogen MA Inc., Cambridge, MA, US
Prosecution history
- 26 Mar 2026 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 14 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Nov 2025 — SOU EXTENSION 2 GRANTED
- 13 Nov 2025 — SOU EXTENSION 2 FILED
- 13 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Aug 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 10 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Apr 2025 — SOU EXTENSION 1 GRANTED
- 10 Apr 2025 — SOU EXTENSION 1 FILED
- 10 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 19 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 08 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Oct 2024 — PUBLISHED FOR OPPOSITION
- 18 Sept 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Sept 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER